Search Results for: Elemental Impurities Implications for Manufacturer
Articles
January 13, 2017
Elemental Impurities: Implications for Manufacturers of Drug Products, APIs & Excipients January 13, 2017
By: Ulrich Reichert, PhD, Head of Pharma & Food Materials, Regulatory Management, Merck KGaA, Darmstadt, Germany Introduction The International Conference...
January 13, 2017
Elemental Impurities: Implications for Manufacturers of Drug Products, APIs & Excipients January 13, 2017
By: Ulrich Reichert, PhD, Head of Pharma & Food Materials, Regulatory Management, Merck KGaA, Darmstadt, Germany Introduction The International Conference...
June 2, 2016
SPECIAL FEATURE - Excipients: Manufacturers Look to Co-Processing as a Way of Improving Functionality June 2, 2016
Contributor Cindy H. Dubin reports how leading excipient manufacturers are overcoming their own R&D challenges to deliver innovative excipients that address problems associated with both large and small molecules.
January 10, 2019
SPECIAL FEATURE - Outsourcing Analytical Testing: The Gateway to Drug Manufacturing January 10, 2019
Contributor Cindy H. Dubin speaks with several leading analytical labs and CDMOs to review their technologies, services, and new strategies to operate in this ever-changing environment.
January 8, 2019
EXTRACTABLES & LEACHABLES - A Practical Approach to Extractables & Leachables January 8, 2019
Cheryl Johnson says the study of E&L has been evolving for many years, and as pharmaceutical manufacturers, packaging vendors, and regulatory agencies gain more knowledge of extractable compounds, the scope of E&L guidelines grows with it.
